BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 19812936)

  • 1. Timing of serum active MMP-9 and MMP-2 levels in acute and subacute phases after spontaneous intracerebral hemorrhage.
    Castellazzi M; Tamborino C; De Santis G; Garofano F; Lupato A; Ramponi V; Trentini A; Casetta I; Bellini T; Fainardi E
    Acta Neurochir Suppl; 2010; 106():137-40. PubMed ID: 19812936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Timing of serum soluble HLA-G levels in acute and subacute phases after spontaneous intracerebral hemorrhage.
    Fainardi E; Rizzo R; Lupato A; Ramponi V; De Santis G; Garofano F; Stignani M; Tamborino C; Castellazzi M; Casetta I; Baricordi OR
    Acta Neurochir Suppl; 2010; 106():141-5. PubMed ID: 19812937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum matrix metalloproteinases -2, -9 and tissue inhibitors of metalloproteinases -1, -2 in lung cancer--TIMP-1 as a prognostic marker.
    Ylisirniö S; Höyhtyä M; Turpeenniemi-Hujanen T
    Anticancer Res; 2000; 20(2B):1311-6. PubMed ID: 10810441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of Liangxue Tongyu Formula on brain edema and expressions of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in rats with intracerebral hemorrhage].
    He CY; Huang JH; Wang WJ; Jin MW; Ye F; Wu HT; Chen WH; Wu MH
    Zhong Xi Yi Jie He Xue Bao; 2010 Apr; 8(4):347-51. PubMed ID: 20388475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of molecular markers with perihematomal edema and clinical outcome in intracerebral hemorrhage.
    Li N; Liu YF; Ma L; Worthmann H; Wang YL; Wang YJ; Gao YP; Raab P; Dengler R; Weissenborn K; Zhao XQ
    Stroke; 2013 Mar; 44(3):658-63. PubMed ID: 23391772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increases in circulating matrix metalloproteinase-9 levels following fibrinolysis for acute pulmonary embolism.
    Mühl D; Ghosh S; Uzuelli JA; Lantos J; Tanus-Santos JE
    Thromb Res; 2010 Jun; 125(6):549-53. PubMed ID: 20307903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Limited value of preoperative serum analyses of matrix metalloproteinases (MMP-2, MMP-9) and tissue inhibitors of matrix metalloproteinases (TIMP-1, TIMP-2) in colorectal cancer.
    Oberg A; Höyhtyä M; Tavelin B; Stenling R; Lindmark G
    Anticancer Res; 2000; 20(2B):1085-91. PubMed ID: 10810401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Profiles of matrix metalloproteinases, their inhibitors, and laminin in stroke patients: influence of different therapies.
    Horstmann S; Kalb P; Koziol J; Gardner H; Wagner S
    Stroke; 2003 Sep; 34(9):2165-70. PubMed ID: 12907822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Expression of matrix metalloproteinase MMP-9 in the plasma and hematoma fluid of intracerebral hemorrhage patients].
    Wu CH; Huang FY; Wang KY; Huang SY; Yang RL; Li HZ; Lei HX; Lin JS; Wang JM; Yan XH
    Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(3):174-6. PubMed ID: 18361815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imbalanced matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 activities in patients with thromboangiitis obliterans.
    Dellalibera-Joviliano R; Jacob-Ferreira AL; Joviliano EE; Tanus-Santos JE; Evora PR
    Vasc Med; 2012 Apr; 17(2):73-8. PubMed ID: 22402936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TIMP-1, MMP-2, MMP-9, and PIIINP as serum markers for skin fibrosis in patients following severe burn trauma.
    Ulrich D; Noah EM; von Heimburg D; Pallua N
    Plast Reconstr Surg; 2003 Apr; 111(4):1423-31. PubMed ID: 12618601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gelatinase A (MM-2), gelatinase B (MMP-9) and their inhibitors (TIMP 1, TIMP-2) in serum of women with endometriosis: Significant correlation between MMP-2, MMP-9 and their inhibitors without difference in levels of matrix metalloproteinases and tissue inhibitors of metalloproteinases in relation to the severity of endometriosis.
    Salata IM; Stojanovic N; Cajdler-Łuba A; Lewandowski KC; Lewiński A
    Gynecol Endocrinol; 2008 Jun; 24(6):326-30. PubMed ID: 18584412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MMP-2 and MMP-9 and their tissue inhibitors in the plasma of preterm and term neonates.
    Schulz CG; Sawicki G; Lemke RP; Roeten BM; Schulz R; Cheung PY
    Pediatr Res; 2004 May; 55(5):794-801. PubMed ID: 14973177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Alterations of metalloproteinases and their inhibitors concentrations in peripheral blood in children with congenital heart disease undergoing cardiac surgery with cardiopulmonary bypass].
    Paśnik J; Cywińska-Bernas A; Moll J; Moll J; Sysa A; Zeman K
    Przegl Lek; 2009; 66(7):359-64. PubMed ID: 20043576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The roles of MMP-9/TIMP-1 in cerebral edema following experimental acute cerebral infarction in rats.
    Li DD; Song JN; Huang H; Guo XY; An JY; Zhang M; Li Y; Sun P; Pang HG; Zhao YL; Wang JF
    Neurosci Lett; 2013 Aug; 550():168-72. PubMed ID: 23819982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in sera and tissue of patients with Dupuytren's disease.
    Ulrich D; Hrynyschyn K; Pallua N
    Plast Reconstr Surg; 2003 Oct; 112(5):1279-86. PubMed ID: 14504511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Temporal profile of matrix metalloproteinases and their inhibitors after spontaneous intracerebral hemorrhage: relationship to clinical and radiological outcome.
    Alvarez-Sabín J; Delgado P; Abilleira S; Molina CA; Arenillas J; Ribó M; Santamarina E; Quintana M; Monasterio J; Montaner J
    Stroke; 2004 Jun; 35(6):1316-22. PubMed ID: 15087562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gelatinases and their tissue inhibitors in ovarian tumors; TIMP-1 is a predictive as well as a prognostic factor.
    Rauvala M; Puistola U; Turpeenniemi-Hujanen T
    Gynecol Oncol; 2005 Dec; 99(3):656-63. PubMed ID: 16112717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Plasma matrix metalloproteinases MMP-2 and MMP-9 and tissue inhibitors TIMP-1 and TIMP-2 in children treated for acute lymphoblastic leukemia].
    Krawczuk-Rybak M; Kuźmicz M; Mroczko B; Szmitkowski M
    Pol Merkur Lekarski; 2010 Jul; 29(169):14-8. PubMed ID: 20712241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Matrix metalloproteinase-9 concentration after spontaneous intracerebral hemorrhage.
    Abilleira S; Montaner J; Molina CA; Monasterio J; Castillo J; Alvarez-Sabín J
    J Neurosurg; 2003 Jul; 99(1):65-70. PubMed ID: 12854746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.